Morgantown, W.Va.-based WVU Medicine has recorded promising results from a yearslong initiative to reduce a common surgical complication among pediatric urology patients.
The effort focused on hypospadias, a common birth defect that affects about 1 in every 200 births. Surgery can correct the condition, but between 5% and 10% of these procedures result in urethrocutaneous fistula, the health system said in a May 13 post. The complication typically requires more surgery.
Osama Al-Omar, MD, chief of pediatric urology at WVU Medicine, developed a technique to avert the surgical complication. Rather than using one or two tissue flaps — the standard approach — Dr. Al-Omar created a novel technique using three layers of well-vascularized tissue flaps, according to the health system.
The technique resulted in zero urethrocutaneous fistula complications among more than 60 consecutive cases. Dr. Al-Omar’s findings are published in the Journal of Pediatric Urology.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
